BRCA2 and ovarian cancer: For risk reduction of ovarian cancer in this population, NCCN guidelines recommend risk-reducing salpingo-oophorectomy (RRSO), typically between age 35–40 and after completion of childbearing, noting that it is reasonable to delay RRSO until age 40–45 among BRCA2 PV carriers [71].